Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

A new MRI marker of ataxia with oculomotor apraxia.

Ronsin S, Hannoun S, Thobois S, Petiot P, Vighetto A, Cotton F, Tilikete C.

Eur J Radiol. 2019 Jan;110:187-192. doi: 10.1016/j.ejrad.2018.11.035. Epub 2018 Nov 29.

PMID:
30599859
2.

Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.

Girard R, Obeso I, Thobois S, Park SA, Vidal T, Favre E, Ulla M, Broussolle E, Krack P, Durif F, Dreher JC.

Brain. 2019 Jan 1;142(1):146-162. doi: 10.1093/brain/awy298.

PMID:
30590514
3.

Age and time course of long-term motor and nonmotor complications in Parkinson disease.

Prange S, Danaila T, Laurencin C, Caire C, Metereau E, Merle H, Broussolle E, Maucort-Boulch D, Thobois S.

Neurology. 2019 Jan 8;92(2):e148-e160. doi: 10.1212/WNL.0000000000006737. Epub 2018 Dec 12.

PMID:
30541866
4.

The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study.

Schmitt E, Krack P, Castrioto A, Klinger H, Bichon A, Lhommée E, Pelissier P, Fraix V, Thobois S, Moro E, Martinez-Martin P.

Mov Disord Clin Pract. 2018 Mar 23;5(3):265-272. doi: 10.1002/mdc3.12607. eCollection 2018 May-Jun.

PMID:
30363450
5.

Molecular Imaging of Opioid System in Idiopathic Parkinson's Disease.

Thobois S, Brefel-Courbon C, Le Bars D, Sgambato-Faure V.

Int Rev Neurobiol. 2018;141:275-303. doi: 10.1016/bs.irn.2018.07.029. Epub 2018 Aug 13.

PMID:
30314599
6.

What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective.

Thobois S, Prange S, Scheiber C, Broussolle E.

Parkinsonism Relat Disord. 2018 Aug 30. pii: S1353-8020(18)30375-4. doi: 10.1016/j.parkreldis.2018.08.016. [Epub ahead of print]

PMID:
30181086
7.

Removing deep brain stimulation artifacts from the electroencephalogram: Issues, recommendations and an open-source toolbox.

Lio G, Thobois S, Ballanger B, Lau B, Boulinguez P.

Clin Neurophysiol. 2018 Oct;129(10):2170-2185. doi: 10.1016/j.clinph.2018.07.023. Epub 2018 Aug 13. Review.

PMID:
30144660
8.

Pathophysiology of levodopa-induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non-human primates.

Beaudoin-Gobert M, Météreau E, Duperrier S, Thobois S, Tremblay L, Sgambato V.

Neuroimage. 2018 Dec;183:132-141. doi: 10.1016/j.neuroimage.2018.08.016. Epub 2018 Aug 10.

PMID:
30102999
9.

Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy.

Lopez-Cuina M, Fernagut PO, Canron MH, Vital A, Lannes B, De Paula AM, Streichenberger N, Guehl D, Damier P, Eusebio A, Houeto JL, Tison F, Tranchant C, Viallet F, Witjas T, Thobois S, Meissner WG.

Neurobiol Dis. 2018 Oct;118:155-160. doi: 10.1016/j.nbd.2018.07.016. Epub 2018 Jul 17.

PMID:
30026036
10.

Toe dystonia in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation.

Laurencin C, Montaut S, Vial C, Bernard L, Bin S, Rascle L, Polo G, Mertens P, Danaila T, Thobois S.

J Neurol Sci. 2018 Sep 15;392:65-68. doi: 10.1016/j.jns.2018.07.004. Epub 2018 Jul 12.

PMID:
30025235
11.

Clonidine modulates the activity of the subthalamic-supplementary motor loop: evidence from a pharmacological study combining deep brain stimulation and electroencephalography recordings in Parkinsonian patients.

Spay C, Albares M, Lio G, Thobois S, Broussolle E, Lau B, Ballanger B, Boulinguez P.

J Neurochem. 2018 Aug;146(3):333-347. doi: 10.1111/jnc.14447.

PMID:
29675956
12.

Novel XK mutation in a McLeod patient diagnosed after heart transplant.

Laurencin C, Sebbag L, Jousserand G, Demontes M, Campean L, Thivolet-Bejui F, Lebre AS, Thobois S.

Clin Neurol Neurosurg. 2018 May;168:64-66. doi: 10.1016/j.clineuro.2018.02.039. Epub 2018 Mar 1. No abstract available.

PMID:
29524658
13.

Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes.

Coutelier M, Hammer MB, Stevanin G, Monin ML, Davoine CS, Mochel F, Labauge P, Ewenczyk C, Ding J, Gibbs JR, Hannequin D, Melki J, Toutain A, Laugel V, Forlani S, Charles P, Broussolle E, Thobois S, Afenjar A, Anheim M, Calvas P, Castelnovo G, de Broucker T, Vidailhet M, Moulignier A, Ghnassia RT, Tallaksen C, Mignot C, Goizet C, Le Ber I, Ollagnon-Roman E, Pouget J, Brice A, Singleton A, Durr A; Spastic Paraplegia and Ataxia Network.

JAMA Neurol. 2018 May 1;75(5):591-599. doi: 10.1001/jamaneurol.2017.5121.

PMID:
29482223
14.

Deep brain stimulation as a therapeutic option for obesity: A critical review.

Bétry C, Thobois S, Laville M, Disse E.

Obes Res Clin Pract. 2018 May - Jun;12(3):260-269. doi: 10.1016/j.orcp.2018.02.004. Epub 2018 Feb 21. Review.

PMID:
29475604
15.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
16.

Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.

Abbes M, Lhommée E, Thobois S, Klinger H, Schmitt E, Bichon A, Castrioto A, Xie J, Fraix V, Kistner A, Pélissier P, Seigneuret É, Chabardès S, Mertens P, Broussolle E, Moro E, Krack P.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):836-843. doi: 10.1136/jnnp-2017-316373. Epub 2018 Feb 7.

PMID:
29436490
17.

Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.

Renaud M, Moreira MC, Ben Monga B, Rodriguez D, Debs R, Charles P, Chaouch M, Ferrat F, Laurencin C, Vercueil L, Mallaret M, M'Zahem A, Pacha LA, Tazir M, Tilikete C, Ollagnon E, Ochsner F, Kuntzer T, Jung HH, Beis JM, Netter JC, Djamshidian A, Bower M, Bottani A, Walsh R, Murphy S, Reiley T, Bieth É, Roelens F, Poll-The BT, Lourenço CM, Jardim LB, Straussberg R, Landrieu P, Roze E, Thobois S, Pouget J, Guissart C, Goizet C, Dürr A, Tranchant C, Koenig M, Anheim M.

JAMA Neurol. 2018 Apr 1;75(4):495-502. doi: 10.1001/jamaneurol.2017.4373.

PMID:
29356829
18.

Historical crossroads in the conceptual delineation of apathy in Parkinson's disease.

Prange S, Pagonabarraga J, Krack P, Kulisevsky J, Sgambato V, Tremblay L, Thobois S, Broussolle E.

Brain. 2018 Feb 1;141(2):613-619. doi: 10.1093/brain/awx362. No abstract available.

PMID:
29329378
19.

Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey.

Météreau E, Beaudoin-Gobert M, Duperrier S, Thobois S, Tremblay L, Sgambato-Faure V.

Mov Disord. 2018 Feb;33(2):298-309. doi: 10.1002/mds.27201. Epub 2017 Oct 27.

PMID:
29076602
20.

Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment.

Thobois S, Prange S, Sgambato-Faure V, Tremblay L, Broussolle E.

Curr Neurol Neurosci Rep. 2017 Aug 18;17(10):76. doi: 10.1007/s11910-017-0788-0. Review.

PMID:
28822071
21.

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

Delpont B, Lhommée E, Klinger H, Schmitt E, Bichon A, Fraix V, Castrioto A, Quesada JL, Pélissier P, Kistner A, Carnicella S, Lüscher C, Broussolle E, Pollak P, Thobois S, Krack P.

Mov Disord. 2017 Nov;32(11):1566-1573. doi: 10.1002/mds.27101. Epub 2017 Jul 24.

PMID:
28737225
22.

Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial.

Welter ML, Houeto JL, Thobois S, Bataille B, Guenot M, Worbe Y, Hartmann A, Czernecki V, Bardinet E, Yelnik J, du Montcel ST, Agid Y, Vidailhet M, Cornu P, Tanguy A, Ansquer S, Jaafari N, Poulet E, Serra G, Burbaud P, Cuny E, Aouizerate B, Pollak P, Chabardes S, Polosan M, Borg M, Fontaine D, Giordana B, Raoul S, Rouaud T, Sauvaget A, Jalenques I, Karachi C, Mallet L; STIC study group.

Lancet Neurol. 2017 Aug;16(8):610-619. doi: 10.1016/S1474-4422(17)30160-6. Epub 2017 Jun 20.

PMID:
28645853
23.

Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation.

Lhommée E, Boyer F, Wack M, Pélissier P, Klinger H, Schmitt E, Bichon A, Fraix V, Chabardès S, Mertens P, Castrioto A, Kistner A, Broussolle E, Thobois S, Krack P.

Mov Disord. 2017 Aug;32(8):1191-1200. doi: 10.1002/mds.27065. Epub 2017 Jun 23.

PMID:
28643887
24.

Optimizing the deep brain stimulation care pathway in patients with Parkinson's disease.

Thomas NJ, Mertens P, Danaila T, Polo G, Klinger H, Broussolle E, Thobois S.

J Neurol. 2017 Jul;264(7):1454-1464. doi: 10.1007/s00415-017-8548-2. Epub 2017 Jun 19.

PMID:
28631129
25.

Amyotrophic lateral sclerosis in Huntington disease gene carrier.

Bernard E, Mouzat K, Leblanc P, Bost M, Lumbroso S, Thobois S, Broussolle E.

Rev Neurol (Paris). 2017 Dec;173(10):670-671. doi: 10.1016/j.neurol.2017.05.005. Epub 2017 Jun 7. No abstract available.

PMID:
28595974
26.

Evidence for dopaminergic denervation in classical galactosemia.

Poisson A, Roze E, Demily C, Thobois S.

Mov Disord. 2017 Jun;32(6):940-942. doi: 10.1002/mds.26980. Epub 2017 Apr 3. No abstract available.

PMID:
28370299
27.

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JÁ, Cilia R, Ballanger B, Niethammer M, Stoessl JA; IPMDS-Neuroimaging Study Group.

Mov Disord. 2017 Feb;32(2):181-192. doi: 10.1002/mds.26907. Epub 2017 Feb 2. Review.

28.

Imagerie cérébrale dans les syndromes parkinsoniens.

Prange S, Hermier M, Danaila T, Laurencin C, Thobois S.

Presse Med. 2017 Mar;46(2 Pt 1):202-209. doi: 10.1016/j.lpm.2016.09.025. Epub 2016 Dec 28. French.

PMID:
28040345
29.

Liver Transplantation in Wilson's Disease with Neurological Impairment: Evaluation in 4 Patients.

Laurencin C, Brunet AS, Dumortier J, Lion-Francois L, Thobois S, Mabrut JY, Dubois R, Woimant F, Poujois A, Guillaud O, Lachaux A, Broussolle E.

Eur Neurol. 2017;77(1-2):5-15. doi: 10.1159/000452658. Epub 2016 Nov 19.

PMID:
27866189
30.

Subthalamic nucleus stimulation effects on single and combined task performance in Parkinson's disease patients: a PET study.

Atkinson-Clement C, Maillet A, LeBars D, Lavenne F, Redouté J, Krainik A, Pollak P, Thobois S, Pinto S.

Brain Imaging Behav. 2017 Aug;11(4):1139-1153. doi: 10.1007/s11682-016-9588-4.

PMID:
27704407
31.

High incidence of carpal tunnel syndrome after deep brain stimulation in Parkinson's disease.

Loizon M, Laurencin C, Vial C, Danaila T, Thobois S.

J Neurol. 2016 Dec;263(12):2416-2418. Epub 2016 Sep 13.

PMID:
27624119
32.

The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.

Maillet A, Krack P, Lhommée E, Météreau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S.

Brain. 2016 Sep;139(Pt 9):2486-502. doi: 10.1093/brain/aww162. Epub 2016 Aug 17.

PMID:
27538418
33.

Initial treatment of Parkinson's disease in 2016: The 2000 consensus conference revisited.

Laurencin C, Danaila T, Broussolle E, Thobois S.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):512-523. doi: 10.1016/j.neurol.2016.07.007. Epub 2016 Jul 29. Review.

PMID:
27476416
34.

A rare case of SPG11 mutation with multiple sclerosis.

Laurencin C, Rascle L, Cotton F, Grosset-Janin C, Bernard E, Depienne C, Vukusic S, Thobois S.

Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):389-91. doi: 10.1016/j.neurol.2016.03.006. Epub 2016 May 11.

PMID:
27180005
35.

Slowness in Movement Initiation is Associated with Proactive Inhibitory Network Dysfunction in Parkinson's Disease.

Criaud M, Poisson A, Thobois S, Metereau E, Redouté J, Ibarrola D, Baraduc P, Broussolle E, Strafella AP, Ballanger B, Boulinguez P.

J Parkinsons Dis. 2016 Apr 2;6(2):433-40. doi: 10.3233/JPD-150750.

PMID:
27061065
36.

A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia.

Hainque E, Vidailhet M, Cozic N, Charbonnier-Beaupel F, Thobois S, Tranchant C, Brochard V, Glibert G, Drapier S, Mutez E, Doe De Maindreville A, Lebouvier T, Hubsch C, Degos B, Bonnet C, Grabli D, Legrand AP, Méneret A, Azulay JP, Bissery A, Zahr N, Clot F, Mallet A, Dupont S, Apartis E, Corvol JC, Roze E.

Neurology. 2016 May 3;86(18):1729-35. doi: 10.1212/WNL.0000000000002631. Epub 2016 Apr 6.

PMID:
27053715
37.

Emotional manifestations of PD: Neurobiological basis.

Castrioto A, Thobois S, Carnicella S, Maillet A, Krack P.

Mov Disord. 2016 Aug;31(8):1103-13. doi: 10.1002/mds.26587. Epub 2016 Apr 4. Review.

PMID:
27041545
38.

Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms.

Ballanger B, Beaudoin-Gobert M, Neumane S, Epinat J, Metereau E, Duperrier S, Broussolle E, Thobois S, Bonnefoi F, Tourvielle C, Lavenne F, Costes N, Lebars D, Zimmer L, Sgambato-Faure V, Tremblay L.

J Neurosci. 2016 Feb 3;36(5):1577-89. doi: 10.1523/JNEUROSCI.2010-15.2016.

39.

Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia.

Pouclet-Courtemanche H, Rouaud T, Thobois S, Nguyen JM, Brefel-Courbon C, Chereau I, Cuny E, Derost P, Eusebio A, Guehl D, Laurencin C, Mertens P, Ory-Magne F, Raoul S, Regis J, Ulla M, Witjas T, Burbaud P, Rascol O, Damier P.

Neurology. 2016 Feb 16;86(7):651-9. doi: 10.1212/WNL.0000000000002370. Epub 2016 Jan 20.

PMID:
26791148
40.

Rapid eye movement sleep behaviour disorder symptomatic of a brain stem cavernoma.

Felix S, Thobois S, Peter-Derex L.

J Sleep Res. 2016 Apr;25(2):211-5. doi: 10.1111/jsr.12364. Epub 2016 Jan 18.

41.

Distinct effects of dopamine vs STN stimulation therapies in associative learning and retention in Parkinson disease.

Ventre-Dominey J, Mollion H, Thobois S, Broussolle E.

Behav Brain Res. 2016 Apr 1;302:131-41. doi: 10.1016/j.bbr.2016.01.010. Epub 2016 Jan 8.

PMID:
26778783
42.

Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature.

Meissner WG, Laurencin C, Tranchant C, Witjas T, Viallet F, Guehl D, Damier P, Houeto JL, Tison F, Eusebio A, Vital A, Streichenberger N, Lannes B, Maues de Paula A, Thobois S.

Parkinsonism Relat Disord. 2016 Mar;24:69-75. doi: 10.1016/j.parkreldis.2016.01.005. Epub 2016 Jan 7. Review.

PMID:
26778473
43.

Massive subcutaneous emphysema and septic shock revealed by a stroke-mimic episode.

Gobert F, Tancredi I, Malick P, Thobois S, Monneuse O.

Rev Neurol (Paris). 2016 Feb;172(2):162-5. doi: 10.1016/j.neurol.2015.09.004. Epub 2015 Oct 20. No abstract available.

PMID:
26494572
44.

Early Illustrations of Geste Antagoniste in Cervical and Generalized Dystonia.

Broussolle E, Laurencin C, Bernard E, Thobois S, Danaila T, Krack P.

Tremor Other Hyperkinet Mov (N Y). 2015 Sep 21;5:332. doi: 10.7916/D8KD1X74. eCollection 2015. Review.

45.

Parkinson's Disease Revealed by a Resting Tongue Tremor.

Jaulent P, Laurencin C, Robert H, Thobois S.

Mov Disord Clin Pract. 2015 Aug 24;2(4):432-433. doi: 10.1002/mdc3.12202. eCollection 2015 Dec. No abstract available.

46.

Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate.

Beaudoin-Gobert M, Epinat J, Météreau E, Duperrier S, Neumane S, Ballanger B, Lavenne F, Liger F, Tourvielle C, Bonnefoi F, Costes N, Bars DL, Broussolle E, Thobois S, Tremblay L, Sgambato-Faure V.

Brain. 2015 Sep;138(Pt 9):2632-47. doi: 10.1093/brain/awv183. Epub 2015 Jun 27.

PMID:
26117365
47.

Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.

Martinez-Fernandez R, Pelissier P, Quesada JL, Klinger H, Lhommée E, Schmitt E, Fraix V, Chabardes S, Mertens P, Castrioto A, Kistner A, Broussolle E, Pollak P, Thobois S, Krack P.

J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):311-8. doi: 10.1136/jnnp-2014-310189. Epub 2015 Apr 30.

PMID:
25934016
48.

Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.

Sierra M, Carnicella S, Strafella AP, Bichon A, Lhommée E, Castrioto A, Chabardes S, Thobois S, Krack P.

J Parkinsons Dis. 2015;5(3):625-36. doi: 10.3233/JPD-150535. Review.

PMID:
25870025
49.

Pitfalls in ataxia with ocular motor apraxia type 1: pseudodominant inheritance and very late onset.

Laurencin C, Anheim M, Larrieu L, Tilikete C, Koenig M, Thobois S.

J Neurol. 2015 May;262(5):1366-8. doi: 10.1007/s00415-015-7717-4. Epub 2015 Apr 7. No abstract available.

PMID:
25845762
50.

Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders.

Tremblay L, Worbe Y, Thobois S, Sgambato-Faure V, Féger J.

Mov Disord. 2015 Aug;30(9):1155-70. doi: 10.1002/mds.26199. Epub 2015 Mar 15. Review.

PMID:
25772380

Supplemental Content

Loading ...
Support Center